Hap Trading, LLC Provention Bio, Inc. Put Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	SELL	$4.52 - $10.57 $1,355 - $3,171	-300 Reduced 0.79%	37,500 $29,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.62 $8,575 - $14,050	-2,500 Reduced 6.2%	37,800 $269,000
Q2 2022 Aug 12, 2022	SELL	$3.65 - $7.3 $730 - $1,460	-200 Reduced 0.49%	40,300 $292,000
Q1 2022 May 12, 2022	BUY	$3.4 - $7.88 $137,700 - $319,140	40,500 New	40,500 $197,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.